Therefore, we chose A549 cells (KRAS mutation, P53 wide-type), NCI-H2228 (EML4-ALK variant 3, P53 Q331* mutation) and HCC-827 (EGFR exon19 deletion mutant, inactivation P53 mutation) with different genetic backgrounds. The gene discussed is ALK; the disease is hepatocellular carcinoma.